Gold tier: mechanically validated evidence, with its primary source.
956 evidence items · page 6 / 39
3.83 odds_ratioIncreasing age was identified as an independent risk factor for hypertension with an odds ratio of 3.83.
Burkina Fasohypertension artériellepublished 2015International journal of hypertensioneurope_pmcdocument of 7 observationsDOI 10.1155/2015/979631
86 %Mixture-treated nets killed 86% of Anopheles gambiae s.l. mosquitoes in the unwashed condition.
Burkina Fasopaludismepublished 2017Malaria journaleurope_pmcdocument of 6 observations
53.7 %Only 53.7% of febrile children with a positive malaria RDT result had malaria confirmed by expert microscopy.
Burkina Fasopaludismepublished 2019Annals of clinical microbiology and antimicrobialseurope_pmcdocument of 4 observationsDOI 10.1186/s12941-019-0304-2
5.6 %The prevalence of severe pneumonia was 5.6% (38/196) in Burkina Faso.
Burkina Fasopneumonie sévèreHAL · Unilimdocument of 187 observations
Ivermectin had no significant impact on fecundity in Aedes aegypti (all p > 0.80).
Burkina FasoarbovirusHAL · Unilimdocument of 5 observations
2.21 %The overall seroprevalence rate of HIV among blood donors in Burkina Faso was 2.21%.
Burkina FasoVIH/sidapublished 2011Blood transfusion = Trasfusione del sangueeurope_pmcdocument of 9 observations
0.495 odds_ratioHIV stigma is negatively associated with HIV seropositivity in young women (OR = 0.495; 95% CI = 0.247, 0.990) in the fully adjusted model.
Burkina FasoVIH/sidapublished 2021Journal of global healthPubMeddocument of 4 observations
34.4 %Malaria prevalence was 34.4% among febrile adults from non-malaria endemic countries who stayed in Burkina Faso for under 3 months and did not use appropriate chemoprophylaxis.
Burkina FasopaludismeHAL · Unilimdocument of 83 observations
61.2 %The dhfr C59R mutation had a prevalence of 61.2% among 255 successfully genotyped samples from pregnant women in Nanoro, Burkina Faso.
Burkina Fasopaludismeobserved 2010published 2015PloS oneeurope_pmcdocument of 8 observations
97 %In the rainy season, the RDT sensitivity for malaria-attributable fever was 97% in Burkina Faso.
Burkina Fasopaludismeobserved rainy seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192
40 %The prevalence of anaemia (PCV <25%) was about 40% at day 0 in children aged 6–59 months with uncomplicated malaria in the province of Houet, Burkina Faso.
Burkina Fasoanémiepublished 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observationsDOI 10.1046/j.1365-3156.2002.00952.x
7 %At first scheduled antenatal visit (ANC1), bacterial vaginosis prevalence was 7.0% among pregnant women.
Burkina Fasovaginose bactériennepublished 2017BMC medicineeurope_pmcdocument of 6 observations
29.4 %The prevalence of HBsAg was 29.4% among the 462 screened patients at Saint Camille Medical Centre.
Burkina Fasohépatite Bobserved 2012published 2012Pakistan journal of biological sciences : PJBSeurope_pmcdocument of 8 observations
12.8 %The prevalence of HBV was 12.8% among HIV-1 seronegative subjects in the study population in Burkina Faso.
Burkina Fasohépatite B · VIH/sidapublished 2016BMC infectious diseaseseurope_pmcdocument of 4 observations
0.33 odds_ratioIn Burkina Faso, the odds of malaria were lower 2 months post-SMC administration, with an odds ratio of 0.33, after controlling for seasonal factors, age, sex, net use and other variables.
Burkina Fasopaludismepublished 2022BMJ global healthPubMeddocument of 8 observations
In the rainy season, the RDT negative predictive value for malaria-attributable fever ranged from 84% for infants to over 99% for adults in Burkina Faso.
Burkina Fasopaludismeobserved rainy seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192
Sickle cell disease is responsible for significant early mortality in Burkina Faso.
Burkina Fasodrépanocytosepublished 2023Le Mali medicaleurope_pmcdocument of 4 observations
L'incidence cumulée du paludisme pendant la grossesse au Burkina Faso et au Mali a connu une augmentation entre 2020 et 2023.
Burkina Faso · Malipaludismeobserved 2020-2023HAL · Unilimdocument of 302 observations
10,925 patientsA total of 10,925 uncomplicated malaria patients were treated with Eurartesim®.
Burkina Fasopaludismepublished 2015Malaria journaleurope_pmcdocument of 7 observations
36 %Unwashed DawaPlus 4.0 achieved 36% mortality and 47.5% blood-feeding inhibition against Anopheles gambiae s.l.
Burkina Fasopaludismeobserved 2016published 2019PloS oneeurope_pmcdocument of 3 observationsDOI 10.1371/journal.pone.0226191
80.2 %The prevalence of the Pfdhps A437G mutation was 80.2% among 101 genotyped samples.
Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations
5.7 %Among SARS-CoV-2 cases in Burkina Faso as of 21 June 2020, 5.7% of deaths occurred in the 15–29 age group.
Burkina FasoCOVID-19observed 21 June 2020HAL · Unilimdocument of 97 observations
3.2 %For a febrile child under 5 in the dry season, the pre-test probability of clinical malaria was 3.2%.
Burkina Fasopaludismeobserved dry seasonpublished 2013PloS oneeurope_pmcdocument of 6 observations
50.4 %Vaccine efficacy of RTS,S/AS01 against clinical malaria was 50.4% in the intention-to-treat population.
Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287
11 %Median HBsAg prevalence was approximately 11% in female blood donors in Burkina Faso.
Burkina Fasohépatite Bpublished 2022Viruseseurope_pmcdocument of 11 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.